Ariella Bar-Gil Shitrit, Ami Ben-Ya’acov, Matan Siterman, Matti Waterman, Ayal Hirsh, Doron Schwartz, Eran Zittan, Yehonatan Adler, Benjamin Koslowsky, Irit Avni-Biron, Yehuda Chowers, Yulia Ron, Eran Israeli, Bella Ungar, Henit Yanai, Nitsan Maharshak, Shomron Ben-Horin, Rami Eliakim, Iris Dotan, Eran Goldin and Uri Kopylov. Safety and effectiveness of ustekinumab for induction of remission in patients with Crohn’s disease: A multicenter Israeli study. United European Gastroenterology Journal, 2020; 8: 418–424. DOI: 10.1177/2050640620902956.
The authors declare that Tawfik Khoury contributed significantly to this work and is a co-author of this publication. He contributed intellectual content to the article and had reviewed and revised the manuscript. The correct authorship of the article should read as:
Ariella Bar-Gil Shitrit, Ami Ben-Ya’acov, Matan Siterman, Matti Waterman, Ayal Hirsh, Doron Schwartz, Eran Zittan, Yehonatan Adler,Tawfik Khoury, Benjamin Koslowsky, Irit Avni-Biron, Yehuda Chowers, Yulia Ron, Eran Israeli, Bella Ungar, Henit Yanai, Nitsan Maharshak, Shomron Ben-Horin, Rami Eliakim, Iris Dotan, Eran Goldin and Uri Kopylov.
Tawfik Khoury’s affiliation should read as: Institute of Gastroenterology, Hebrew University Hadassah Medical Center, affiliated with the Faculty of Medicine, Hebrew University, Jerusalem, Israel.